| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |